Projects per year
Personal profile
Field of Science
- 3.1 Basic medicine
Fingerprint
Dive into the research topics where Viktorija Igumnova is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Tuberculosis treatment: exploring the perspectives for personalized therapy
Bandere, D., Igumnova, V., Vīksna, A. & Sadovska, D.
1/01/21 → 31/12/23
Project: Fundamental and Applied Research Programme
-
Assessment of genetic factors in tuberculosis cases
Ranka, R., Igumnova, V., Aļeiņikova, D. & Freimane, L.
1/09/20 → 31/08/21
Project: RSU grants
-
Clinical and pharmacogenomic implications of xanthine dehydrogenase genetic variation in Latvian tuberculosis patients
Vīksna, A., Igumnova, V., Kivrāne, A., Freimane, L., Pole, I., Bandere, D., Ozere, I. & Ranka, R., 2021, In: Medicina (Kaunas). 57, Suppl.1, p. 258Research output: Contribution to journal › Meeting Abstract › peer-review
-
Construction of SARS-CoV-2 E gene plasmids for development of an in-house method for quantification of viral RNA in patient samples
Liepiņa, E. E., Kivrāne, A., Igumnova, V. & Ranka, R., 24 Mar 2021, p. 289.Research output: Contribution to conference › Abstract › peer-review
-
Implementation of a next-generation sequencing-based targeted approach for full-length CYP3A4 gene sequencing
Kivrane, A., Igumnova, V., Kimsis, J., Freimane, L., Sadovska, D., Viksna, A., Pole, I. & Ranka, R., Jun 2021, In: Pharmacogenomics. 22, 9, p. 519-527 9 p.Research output: Contribution to journal › Article › peer-review
-
LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring
Kivrane, A., Grinberga, S., Sevostjanovs, E., Igumnova, V., Pole, I., Viksna, A., Bandere, D., Krams, A., Cirule, A., Pugovics, O. & Ranka, R., 15 Nov 2021, In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 1185, 122986.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Mapping the potential of pharmaco-metabolomics for personalized antituberculosis therapy
Igumnova, V., Kivrāne, A., Freimane, L., Pole, I., Vīksna, A., Čapligina, V., Sevostjanovs, E., Grīnberga, S., Bandere, D. & Ranka, R., 24 Mar 2021, p. 253.Research output: Contribution to conference › Abstract › peer-review
Activities
- 1 Oral presentation
-
Mapping the potential of pharmaco-metabolomics for personalized antituberculosis therapy
Viktorija Igumnova (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation